Cellectar Biosciences, Inc.

NASDAQ:CLRB

2.11 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Assets:
Current Assets:
Cash & Cash Equivalents 9.56519.86635.70457.16510.61513.25610.00611.4453.8589.4232.4184.6785.5062.3738.771.2629.7429.9384.267
Short Term Investments 000000.0550.0550.0550.0550000000000
Cash and Short Term Investments 9.56519.86635.70457.16510.61513.25610.00611.4453.8589.4232.4184.6785.5062.3738.771.2629.7429.9384.267
Net Receivables 0000000000000000000
Inventory 0000000000000000000
Other Current Assets 0.8880.6630.8670.7740.7710.6410.9330.7490.2680.2760.350.3270.310.0640.1030.131.3181.950.535
Total Current Assets 10.45320.5336.57157.9411.38613.95210.93912.1934.1819.6982.7685.135.8162.4368.8721.39211.0611.8894.802
Non-Current Assets:
Property, Plant & Equipment, Net 1.5930.9790.5490.6380.7840.5430.2451.4441.7282.0342.3612.6453.0450.0090.0440.0580.0330.0240.023
Goodwill 0000001.6751.6751.6751.6751.6751.6751.675000000
Intangible Assets 0000001.6751.6751.6750000000000
Goodwill and Intangible Assets 0000001.6751.6751.6751.6751.6751.6751.675000000
Long Term Investments 00000000000000.0150.0150000
Tax Assets 0000000000000000000
Other Non-Current Assets 0.030.0810.0810.0810.0810.5590.0120.0120.0120.0120.0122.0270.027000.0150.0150.0110.114
Total Non-Current Assets 1.6221.060.630.720.8651.1021.9323.1313.4163.7214.0486.3484.7470.0240.0590.0740.0480.0350.137
Total Assets 12.07621.5937.20258.65912.25115.05412.87115.3257.59613.426.81611.47810.5632.4618.9321.46611.10811.9234.939
Liabilities & Equity:
Current Liabilities:
Account Payables 5.622.5581.4151.4291.2780.6121.8681.4160.0010.0010.0010.7170.4780.5663.29906.3721.0880.211
Short Term Debt 0.0590.0510.1350.120.1060.0020.0030.0890.2460.1220.0020.0020.00203.1490000
Tax Payables 0000000000000000000
Deferred Revenue 002.442.0141.3860.965-1.868-1.416-0.001-0.001-0.001000.0330.0330.033000
Other Current Liabilities 7.2592.92-00-00.0432.1121.5445.4572.0624.5210.0130.0230.28810.4876.5840.6870.2250.006
Total Current Liabilities 12.9385.5293.993.5632.771.6222.1151.6335.7032.1854.5230.7330.5040.88716.9686.6177.0591.3130.217
Non-Current Liabilities:
Long Term Debt 0.4940.5530.1660.3020.42200.0020.0050.0950.3410.450.4520.454000000
Deferred Revenue Non-Current 0000000000000.1240.3670.40.433000
Deferred Tax Liabilities Non-Current 000000000000-0.124000000
Other Non-Current Liabilities 00-0000.17100.1470.1490.1480.1430.1350.124018.4609.91900
Total Non-Current Liabilities 0.4940.5530.1660.3020.4220.1710.0020.1520.2440.4890.5930.5870.5780.36718.860.4339.91900
Total Liabilities 13.4326.0824.1573.8653.1911.7932.1171.7855.9472.6745.1161.321.0821.25435.8277.05116.9781.3130.217
Equity:
Preferred Stock 6.061.3821.38220.0361.1482.5260.9960.876000002.46118.4613.9049.91900
Common Stock 000.00100000000.001000.0050.0010000
Retained Earnings -217.483-179.499-150.898-126.775-111.681-97.588-84.349-70.787-64.607-59.166-51.06-40.277-31.48-73.977-76.072-59.693-43.242-23.685-15.399
Accumulated Other Comprehensive Income/Loss -1.38200000000-0-000-2.461-18.460-9.91900
Other Total Stockholders Equity 211.449193.624182.56161.534119.592108.32394.10883.45166.25669.91252.75950.43540.96175.17949.17640.20437.37134.29420.12
Total Shareholders Equity -1.35615.50833.04554.7959.05913.26110.75413.541.6510.7461.710.1589.4811.207-26.896-5.585-5.8710.614.722
Total Equity -1.35615.50833.04554.7959.05913.26110.75413.541.6510.7461.710.1589.4811.207-26.896-5.585-5.8710.614.722
Total Liabilities & Shareholders Equity 12.07621.5937.20258.65912.25115.05412.87115.3257.59613.426.81611.47810.5632.4618.9321.46611.10811.9234.939